http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2012032766-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2011-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2012032766-A1 |
| titleOfInvention | Method for diagnosing Alzheimer's disease using soluble GPVI in blood |
| abstract | The present invention provides a non-invasive and simple diagnostic agent for Alzheimer's disease, a diagnostic method for Alzheimer's disease based on the measurement, and a measurement kit therefor. The present invention relates to a specific reagent for Alzheimer's disease comprising a reagent for measuring soluble GPVI (sGPVI) in human body fluid, and a reagent for measuring activation of platelets or coagulation / fibrinolytic system in the human body fluid. Specific diagnosis of Alzheimer's disease comprising a diagnostic agent, a step of measuring the concentration of sGPVI in a collected human body fluid, and a step of measuring the activation of platelets or coagulation / fibrinolytic system in the human body fluid On how to do. |
| priorityDate | 2010-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 331.